Company Overview
About Cytokinetics
Cytokinetics is a late-stage biopharmaceutical company committed to developing potential medicines for people with diseases of impaired muscle function. Based in the United States, the company has approximately 201 employees and is focused on advancing its robust pipeline of small molecule muscle activators and inhibitors to address conditions such as heart failure and hypertrophic cardiomyopathy.
Frequently Asked Questions about Cytokinetics
Technologies Used
Social Profiles
Key Decision Makers
Robert Blum President
Kathleen L. J. McCullough Sr. Clinical Trial Manager
Gerri Wood Senior Clinical Trial Manager Consultant
Justin Godown, MD, FAHA Medical Director, Clinical Research Cardiovascular
Alexander Ng Clinical Trial Manager
Kyle Jennings Clinical Trial Manager II
Ryan Bright Clinical Trial Manager II
Daniel Jacoby Executive Medical Director, Clinical Research
Robert Lew Senior Clinical Trial Manager
Danny Yee Senior Clinical Trial Manager - Cardiovascular